标题
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
作者
关键词
-
出版物
BIODRUGS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-18
DOI
10.1007/s40259-019-00367-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A CD40 agonist and PD-1 antagonist antibody reprogram the microenvironment of non-immunogenic tumors to allow T cell-mediated anticancer activity
- (2019) Hayley S. Ma et al. Cancer Immunology Research
- Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
- (2019) Jana de Sostoa et al. Journal for ImmunoTherapy of Cancer
- A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
- (2019) Jean-Pascal Machiels et al. Journal for ImmunoTherapy of Cancer
- The Antiviral Apparatus: STING and Oncolytic Virus Restriction
- (2019) Joel Lee et al. Molecular Therapy-Oncolytics
- Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition
- (2019) Victoria A. Jennings et al. MOLECULAR THERAPY
- Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
- (2019) Venkatesh Sivanandam et al. Molecular Therapy-Oncolytics
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Armed oncolytic viruses: A kick-start for anti-tumor immunity
- (2018) J.F. de Graaf et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Driving cars to the clinic for solid tumors
- (2018) Mauro Castellarin et al. GENE THERAPY
- Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma
- (2018) Dipongkor Saha et al. Immunotherapy
- Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies
- (2018) Jacob P. van Vloten et al. JOURNAL OF IMMUNOLOGY
- Superagonist IL-15-armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
- (2018) Stacy J. Kowalsky et al. MOLECULAR THERAPY
- Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition
- (2018) Mohammed Selman et al. Science Translational Medicine
- Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
- (2018) Marie-Claude Bourgeois-Daigneault et al. Science Translational Medicine
- Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
- (2018) Adel Samson et al. Science Translational Medicine
- Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
- (2018) Shashi Gujar et al. TRENDS IN IMMUNOLOGY
- Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells
- (2018) Hiroshi Nakashima et al. Scientific Reports
- TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
- (2018) V. Cervera-Carrascon et al. OncoImmunology
- Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV POS Cancers
- (2018) Lukkana Suksanpaisan et al. Molecular Therapy-Oncolytics
- Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
- (2018) Carole Achard et al. EBioMedicine
- Fusogenic Viruses in Oncolytic Immunotherapy
- (2018) Teresa Krabbe et al. Cancers
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment
- (2018) Amanda Rosewell Shaw et al. Frontiers in Immunology
- An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells
- (2018) Joshua D. Freedman et al. CANCER RESEARCH
- Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming
- (2018) Alfonso R. Sánchez-Paulete et al. CANCER RESEARCH
- Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy
- (2018) Carmela Passaro et al. CLINICAL CANCER RESEARCH
- Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity
- (2018) Scott R. Walsh et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
- (2018) Dmitriy Zamarin et al. JOURNAL OF CLINICAL INVESTIGATION
- Ovarian Cancer Cells Commonly Exhibit Defective STING Signaling Which Affects Sensitivity to Viral Oncolysis
- (2018) Nina Marí Gual Pimenta de Queiroz et al. MOLECULAR CANCER RESEARCH
- MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation
- (2018) Praveen K. Bommareddy et al. Science Translational Medicine
- Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2
- (2018) Zuqiang Liu et al. Nature Communications
- Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model
- (2018) Lukasz Kuryk et al. OncoImmunology
- Oncolytic virus immunotherapy: future prospects for oncology
- (2018) Junaid Raja et al. Journal for ImmunoTherapy of Cancer
- Designing and building oncolytic viruses
- (2017) Justin Maroun et al. Future Virology
- Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy
- (2017) K R Kelly et al. LEUKEMIA
- Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy
- (2017) Kevin G. Shim et al. MOLECULAR THERAPY
- Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
- (2017) Amanda Rosewell Shaw et al. MOLECULAR THERAPY
- Oncolytic Virotherapy: A Contest between Apples and Oranges
- (2017) Stephen J. Russell et al. MOLECULAR THERAPY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma
- (2017) Maria-Carmela Speranza et al. NEURO-ONCOLOGY
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
- (2017) Alice O. Kamphorst et al. SCIENCE
- Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen–specific CTLs
- (2017) Michael C. Brown et al. Science Translational Medicine
- Review: Oncolytic virotherapy, updates and future directions
- (2017) Christos Fountzilas et al. Oncotarget
- Customized Viral Immunotherapy for HPV-Associated Cancer
- (2017) Matthew J. Atherton et al. Cancer Immunology Research
- A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
- (2017) Jeremy B. Foote et al. Cancer Immunology Research
- Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
- (2017) Zong Sheng Guo et al. Frontiers in Immunology
- Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma
- (2017) Alena C. Jaime-Ramirez et al. Molecular Therapy-Oncolytics
- Oncolytic Viruses in Cancer Treatment
- (2017) Sean E. Lawler et al. JAMA Oncology
- Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
- (2017) Rocio Garcia-Carbonero et al. Journal for ImmunoTherapy of Cancer
- Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
- (2017) Jie Yin et al. Frontiers in Oncology
- Oncolytic Viruses—Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer
- (2017) Anwen Howells et al. Frontiers in Oncology
- Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
- (2017) Chun-Yu Chen et al. Scientific Reports
- Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
- (2016) M. Sabatino et al. BLOOD
- Abstract CT021: Phase Ib study of a novel immunotherapy combination therapy of intralesional coxsackievirus A21 and systemic ipilimumab in patients with advanced melanoma
- (2016) Brendan Curti et al. CANCER RESEARCH
- Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis
- (2016) Tianli Xia et al. CANCER RESEARCH
- Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
- (2016) Karishma Rajani et al. MOLECULAR THERAPY
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
- (2015) W. Shen et al. BLOOD
- Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy
- (2015) J. J. Rojas et al. CLINICAL CANCER RESEARCH
- Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
- (2015) Norman Woller et al. MOLECULAR THERAPY
- Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling
- (2015) Julia V. Cockle et al. NEURO-ONCOLOGY
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer
- (2014) E. Galanis et al. CANCER RESEARCH
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- (2014) Christine E Engeland et al. MOLECULAR THERAPY
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy
- (2013) Byram W Bridle et al. MOLECULAR THERAPY
- T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy
- (2013) Feng Yu et al. MOLECULAR THERAPY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Learning from the Messengers: Innate Sensing of Viruses and Cytokine Regulation of Immunity — Clues for Treatments and Vaccines
- (2013) Jesper Melchjorsen Viruses-Basel
- Systemic Combination Virotherapy for Melanoma with Tumor Antigen-Expressing Vesicular Stomatitis Virus and Adoptive T-cell Transfer
- (2012) D. M. Rommelfanger et al. CANCER RESEARCH
- A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity
- (2012) J. R. Tysome et al. CLINICAL CANCER RESEARCH
- Sorting Through Subsets
- (2012) Christopher A. Klebanoff et al. JOURNAL OF IMMUNOTHERAPY
- Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
- (2012) Jose Pulido et al. NATURE BIOTECHNOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Measles virus causes immunogenic cell death in human melanoma
- (2011) O G Donnelly et al. GENE THERAPY
- Activating Systemic T-Cell Immunity Against Self Tumor Antigens to Support Oncolytic Virotherapy with Vesicular Stomatitis Virus
- (2011) Phonphimon Wongthida et al. HUMAN GENE THERAPY
- Targeting Tumor Vasculature With an Oncolytic Virus
- (2011) Caroline J Breitbach et al. MOLECULAR THERAPY
- Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
- (2010) M. J. Besser et al. CLINICAL CANCER RESEARCH
- Potentiating Cancer Immunotherapy Using an Oncolytic Virus
- (2010) Byram W Bridle et al. MOLECULAR THERAPY
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors
- (2008) Y Gao et al. CANCER GENE THERAPY
- Measles Virus Induces Oncolysis of Mesothelioma Cells and Allows Dendritic Cells to Cross-Prime Tumor-Specific CD8 Response
- (2008) A. Gauvrit et al. CANCER RESEARCH
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
- (2008) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now